• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学和生理学引导下无造影剂的经皮冠状动脉介入治疗在晚期肾衰竭患者中的可行性、安全性及疗效研究

Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study.

作者信息

Ali Ziad A, Karimi Galougahi Keyvan, Nazif Tamim, Maehara Akiko, Hardy Mark A, Cohen David J, Ratner Lloyd E, Collins Michael B, Moses Jeffrey W, Kirtane Ajay J, Stone Gregg W, Karmpaliotis Dimitri, Leon Martin B

机构信息

Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA

Cardiovascular Research Foundation, New York, NY, USA.

出版信息

Eur Heart J. 2016 Oct 21;37(40):3090-3095. doi: 10.1093/eurheartj/ehw078. Epub 2016 Mar 7.

DOI:10.1093/eurheartj/ehw078
PMID:26957421
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6279210/
Abstract

AIMS

The feasibility, safety, and clinical utility of percutaneous coronary intervention (PCI) without radio-contrast medium in patients with advanced chronic kidney disease (CKD) are unknown. In this series, we investigated a specific strategy for 'zero contrast' PCI with the aims of preserving renal function and preventing the need for renal replacement therapy (RRT) in patients with advanced CKD.

METHODS AND RESULTS

A total of 31 patients with advanced CKD [creatinine = 4.2 mg/dL, inter-quartile range (IQR) 3.1-4.8, estimated glomerular filtration rate = 16 ± 8 mL/min/1.73 m] who had clinical indication for PCI based on a prior minimal contrast coronary angiogram were included. Zero contrast PCI was performed at least 1 week after diagnostic angiography using real-time intravascular ultrasound (IVUS) guidance, with pre- and post-PCI measurements of fractional flow reserve and coronary flow reserve to confirm physiological improvement. This approach resulted in successful PCI, no major adverse cardiovascular events and preservation of renal function without the need for RRT within a follow-up time of 79 days (IQR 33-207) in all patients.

CONCLUSION

In patients with advanced CKD who require revascularization, PCI may safely be performed without contrast using IVUS and physiological guidance with high procedural success and without complications.

摘要

目的

对于晚期慢性肾脏病(CKD)患者,不使用放射性造影剂进行经皮冠状动脉介入治疗(PCI)的可行性、安全性及临床实用性尚不清楚。在本系列研究中,我们探讨了一种“零造影剂”PCI的特定策略,旨在保护晚期CKD患者的肾功能并避免其需要肾脏替代治疗(RRT)。

方法与结果

共有31例晚期CKD患者[肌酐=4.2mg/dL,四分位数间距(IQR)3.1 - 4.8,估计肾小球滤过率=16±8mL/min/1.73m²]纳入研究,这些患者基于之前的最小造影剂冠状动脉造影有PCI的临床指征。在诊断性血管造影至少1周后,使用实时血管内超声(IVUS)引导进行零造影剂PCI,并在PCI前后测量血流储备分数和冠状动脉血流储备以确认生理改善情况。该方法在所有患者79天(IQR 33 - 207)的随访期内均成功完成PCI,无重大不良心血管事件,且肾功能得以保留,无需RRT。

结论

对于需要血运重建的晚期CKD患者,使用IVUS和生理指标引导,不使用造影剂进行PCI可能安全可行,手术成功率高且无并发症。

相似文献

1
Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study.影像学和生理学引导下无造影剂的经皮冠状动脉介入治疗在晚期肾衰竭患者中的可行性、安全性及疗效研究
Eur Heart J. 2016 Oct 21;37(40):3090-3095. doi: 10.1093/eurheartj/ehw078. Epub 2016 Mar 7.
2
Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.零对比光相干断层扫描引导下经皮冠状动脉介入治疗非 ST 段抬高型心肌梗死合并慢性肾脏病患者。
Catheter Cardiovasc Interv. 2021 May 1;97 Suppl 2:1072-1079. doi: 10.1002/ccd.29655. Epub 2021 Mar 25.
3
Feasibility, Safety, and Long-Term Outcomes of Zero-Contrast Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.慢性肾脏病患者零造影剂经皮冠状动脉介入治疗的可行性、安全性及长期预后
Circ J. 2022 Apr 25;86(5):787-796. doi: 10.1253/circj.CJ-21-0905. Epub 2022 Feb 10.
4
Outcomes of ultra-low contrast percutaneous coronary intervention in patients with advanced chronic kidney disease.超高对比经皮冠状动脉介入治疗在晚期慢性肾脏病患者中的结局。
Catheter Cardiovasc Interv. 2024 Aug;104(2):227-233. doi: 10.1002/ccd.31128. Epub 2024 Jun 26.
5
Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease.血管内超声引导下最小造影剂冠状动脉介入治疗对4期或5期晚期慢性肾脏病患者1年临床结局的影响。
Cardiovasc Interv Ther. 2019 Jul;34(3):234-241. doi: 10.1007/s12928-018-0552-7. Epub 2018 Oct 20.
6
Safety and feasibility of intravascular ultrasound guided zero-contrast percutaneous coronary intervention-A prospective study.血管内超声引导下零造影剂经皮冠状动脉介入治疗的安全性和可行性——一项前瞻性研究
Int J Cardiol. 2022 Apr 15;353:22-28. doi: 10.1016/j.ijcard.2022.01.034. Epub 2022 Jan 20.
7
Absolute zero-contrast percutaneous coronary interventions: An intravascular ultrasound-guided case series and literature review.零对比经皮冠状动脉介入治疗:血管内超声引导下的病例系列及文献复习。
Cardiovasc Revasc Med. 2024 May;62:95-104. doi: 10.1016/j.carrev.2023.12.008. Epub 2023 Dec 17.
8
Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.经皮冠状动脉介入治疗钙化病变时应用旋磨术辅助实现零造影剂操作
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):E85-E89. doi: 10.1002/ccd.26999. Epub 2017 Mar 17.
9
Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures.两种不同连续性肾脏替代治疗方案对接受冠状动脉介入手术的慢性肾功能不全患者的影响。
J Invasive Cardiol. 2013 Feb;25(2):80-4.
10
Zero contrast retrograde chronic total occlusions percutaneous coronary intervention: a case series.零造影剂逆行慢性完全闭塞病变经皮冠状动脉介入治疗:病例系列
Eur Heart J Case Rep. 2018 Apr 2;2(2):1-5. doi: 10.1093/ehjcr/yty036. eCollection 2018 Jun.

引用本文的文献

1
Intravascular Ultrasound Imaging-Guided Percutaneous Coronary Intervention: Evidence and Practical Implications.血管内超声成像引导下的经皮冠状动脉介入治疗:证据与实际意义。
Methodist Debakey Cardiovasc J. 2025 Aug 12;21(4):26-36. doi: 10.14797/mdcvj.1611. eCollection 2025.
2
Microcatheter selective injection technique using ultra low contrast for percutaneous coronary intervention in patients with previous acute kidney injury: a case report.微导管选择性注射技术联合超低剂量造影剂在既往有急性肾损伤患者经皮冠状动脉介入治疗中的应用:一例报告
Front Cardiovasc Med. 2025 Jul 10;12:1607466. doi: 10.3389/fcvm.2025.1607466. eCollection 2025.
3
Deep learning for the prediction of acute kidney injury after coronary angiography and intervention in patients with chronic kidney disease: a model development and validation study.深度学习用于预测慢性肾脏病患者冠状动脉造影和介入治疗后的急性肾损伤:一项模型开发与验证研究
Ren Fail. 2025 Dec;47(1):2474206. doi: 10.1080/0886022X.2025.2474206. Epub 2025 Mar 13.
4
Sex-Specific Analysis of Carotid Artery Through Bilateral 3D Modeling via MRI and DICOM Processing.通过MRI和DICOM处理进行双侧三维建模对颈动脉的性别特异性分析
Bioengineering (Basel). 2025 Feb 1;12(2):142. doi: 10.3390/bioengineering12020142.
5
Study of fluoroscopic landmarks in IVUS guided zero contrast PCI - A single centre experience.血管内超声引导下零造影剂冠状动脉介入治疗中透视标记的研究——单中心经验
Indian Heart J. 2025 Mar-Apr;77(2):78-83. doi: 10.1016/j.ihj.2025.02.006. Epub 2025 Feb 20.
6
Kidney protection strategy lowers the risk of contrast-associated acute kidney injury.肾脏保护策略降低了造影剂相关急性肾损伤的风险。
PLoS One. 2024 Oct 24;19(10):e0312618. doi: 10.1371/journal.pone.0312618. eCollection 2024.
7
Intravascular Imaging for Percutaneous Coronary Intervention Guidance and Optimization: The Evidence for Improved Patient Outcomes.用于经皮冠状动脉介入治疗指导与优化的血管内成像:改善患者预后的证据
J Soc Cardiovasc Angiogr Interv. 2022 Aug 5;1(6):100413. doi: 10.1016/j.jscai.2022.100413. eCollection 2022 Nov-Dec.
8
Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions.需要进行心血管导管插入术的肾病患者的管理:由美国国家肾脏基金会和心血管造影与介入学会联合主办的科学研讨会
J Soc Cardiovasc Angiogr Interv. 2022 Aug 26;1(6):100445. doi: 10.1016/j.jscai.2022.100445. eCollection 2022 Nov-Dec.
9
Imaging in Percutaneous Coronary Intervention.经皮冠状动脉介入治疗中的影像学
Rev Cardiovasc Med. 2022 May 31;23(6):204. doi: 10.31083/j.rcm2306204. eCollection 2022 Jun.
10
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury prevention.应对肾毒性风险:对比剂诱导的急性肾损伤预防全面概述
World J Radiol. 2024 Jun 28;16(6):168-183. doi: 10.4329/wjr.v16.i6.168.

本文引用的文献

1
Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration.光学相干断层扫描引导下的经皮冠状动脉介入治疗在无放射性造影剂使用的终末期慢性肾病患者中的应用
Eur Heart J. 2016 Apr 1;37(13):1059. doi: 10.1093/eurheartj/ehv667. Epub 2015 Dec 18.
2
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials.经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤对短期和长期预后的影响:来自HORIZONS-AMI和ACUITY试验的汇总分析
Circ Cardiovasc Interv. 2015 Aug;8(8):e002475. doi: 10.1161/CIRCINTERVENTIONS.114.002475.
3
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.血流储备分数的预后价值:将生理学严重程度与临床结果联系起来。
J Am Coll Cardiol. 2014 Oct 21;64(16):1641-54. doi: 10.1016/j.jacc.2014.07.973.
4
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
5
Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.血流动力学指导的液体管理预防对比剂急性肾损伤:POSEIDON 随机对照试验。
Lancet. 2014 May 24;383(9931):1814-23. doi: 10.1016/S0140-6736(14)60689-9.
6
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后:来自国家心血管数据注册库(NCDR)导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.
7
A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention).经桡动脉与股动脉入路行冠状动脉旁路移植血管造影和介入治疗的随机对比:RADIAL-CABG 试验(经桡动脉与股动脉入路行冠状动脉旁路移植血管造影和介入治疗的比较)。
JACC Cardiovasc Interv. 2013 Nov;6(11):1138-44. doi: 10.1016/j.jcin.2013.08.004. Epub 2013 Oct 16.
8
Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation.新一代药物洗脱支架置入后血管内超声预测边缘再狭窄。
Am J Cardiol. 2013 May 15;111(10):1408-14. doi: 10.1016/j.amjcard.2013.01.288. Epub 2013 Feb 20.
9
Successful stent implantation guided by intravascular ultrasound and a Doppler guidewire without contrast injection in a patient with allergy to iodinated contrast media.在一名对碘化造影剂过敏的患者中,在未注射造影剂的情况下,通过血管内超声和多普勒导丝引导成功植入支架。
J Invasive Cardiol. 2011 Jul;23(7):297-9.
10
A novel technique for ultra-low contrast administration during angiography or intervention.一种用于血管造影或介入治疗时超低对比度给药的新方法。
Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1076-83. doi: 10.1002/ccd.22414.